Nevertheless, we demonstrated that BCA-M treatment in all tested human cervical cancer cell lines commonly induced a down-regulation of cyclin B1 gene expression and induced cell cycle arrest at S and/or G2/M phases. The gene discussed is CCNB1; the disease is cervical carcinoma.